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Congestive heart failure (CHF) is associated with a significant economic burden that 
includes frequent emergency department visits, hospitalizations, and readmissions. The 
purpose of this study was to examine the differences, if any, between hospital 
readmission rates and insurance reimbursement rates for non-Hispanic Black and White 
CHF patients in California. The theoretical framework was Bandura’s social cognitive 
theory. Secondary data for this quantitative study were obtained from the Office of 
Statewide Health Planning and Development and State Inpatient Databases from 
Healthcare Cost and Utilization for calendar year 2014-2016. A t-test and Levene’s test 
for equality of variance were conducted on a sample of 11,905 patient records from 675 
hospitals in California; the readmission discharge data and insurance reimbursement rates 
were analyzed by ethnicity and payer type. The results indicated that there was not a 
statistically significant difference between non-Hispanic Blacks as compared to non-
Hispanic Whites in relation to readmission rates (M = 49.6, SD = 38.28) or insurance 
reimbursement rates (M = 50.88, SD = 36.52). Non-Hispanic Blacks had a higher 
readmission rate (36%) as compared to Whites (29%), and although these results are not 
significant, they support the need for healthcare professionals to develop programs that 
meet the needs of the community. The results of this study contribute to positive social 
change by providing information that healthcare professionals may be able to use to 
decrease CHF readmissions and improve access to care for non-Hispanic Blacks and 
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Section 1: Foundation of the Study and Literature Review 
Introduction 
Congestive heart failure (CHF) is the most common reason for hospital 
readmission among Blacks, non-Hispanic ages 18-64. It is a progressive disease that 
afflicts about five million persons in the United States, and African Americans have a 
disproportionately high prevalence, especially among young adults (Fonarrow, Konstam, 
& Yancy, 2017). According to American Heart Association (2017) statistics, the annual 
incidence of heart failure for African Americans is 9.1 per 1,000 per year as compared to 
their White counterparts who have a frequency of six incidents per 1,000 per year. As 
rehospitalizations continue to increase, reducing hospital readmission rates has become a 
significant concern for health care leaders and insurance companies as they seek to 
determine the specific causes and the cost burden associated with readmissions for all 
patients. The goal of these efforts is to decrease the cost of care, improve outcomes, and 
minimize insurance reimbursement penalties (Diaz-Maclnnis, 2018). 
Problem Statement 
CHF is an escalating health problem in the United States, and the highest cause of 
death among Blacks, non-Hispanic (Pandey et al., 2015).  Hospital readmission rates for 
Blacks continue to increase due to lack of insurance, low reimbursement rates, and 
limited access to care (Pandey et al., 2016, p. 938).  CHF is associated with a significant 
economic burden that includes frequent emergency department visits, hospitalization, and 
rehospitalization in Black communities.  The rampant nature of CHF readmissions among 
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Black patients is due to insurance restrictions or the inability of Black patients to pay for 
medical care, according to the U.S. Department of Health and Human Services (2017). 
Compared to Whites, non-Hispanic with CHF, Blacks are more likely to be under 
age 65 with limited financial resources and a higher level of hospital readmissions 
(Pandey et al., 2016). In addition, Black patients have higher uninsured rates than White 
patients, which consequently increases hospital readmissions for CHF (Sharma et al., 
2016). The increased clinical and financial burden of this condition, especially among 
young and older adults, had led to an interest among hospital administrators in improving 
outcomes and decreasing the cost of care (Sharma et al., 2016). Even though there is a 
plethora of research on CHF, there is a gap in the literature and a lack of research about 
insurance coverage and insurance reimbursement rates associated with readmissions and 
differences between non-Hispanic Black and White patients (Levesque, Harris, & 
Russell, 2015). I addressed this gap by conducting correlational research.   
Purpose of the Study 
The purpose of this study was to examine the differences between hospital 
readmission and insurance reimbursement rates, if any, for non-Hispanic Blacks and 
Whites with CHF in California.  Research on the causes of CHF readmissions could 
improve health system protocols and enhance access to healthcare by encouraging Black 
patients with CHF to follow up with their primary care physician after hospital discharge. 
Involving the executive leadership team in the patient readmission process using clear 
metrics allows health care administrators to explore necessary adjustments and execute 
strategies for setting and achieving patient goals (Wei et al., 2018).   
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Access to health care is essential to quality patient care, and, as a result, U.S. 
hospital administrators are focusing on efforts to improve the quality of care and reduce 
spending on readmissions. The Patient Protection and Affordable Care Act (PPACA) of 
2010 has spurred administrators to undertake these efforts (Erdem, Fout, Korda, & 
Abolude, 2016). In this study, I used t-test analysis to determine if there were statistically 
significant differences between non-Hispanic Black and White CHF patients in relation 
to hospital readmission rates, insurance reimbursement rates, and uninsured patients. The 
dependent variable for this study was CHF readmission rates for non-Hispanic Black and 
White patients in California.  The independent variable was insurance reimbursement 
rates for non-Hispanic Black and White CHF patients in California. Insurance 
reimbursement included an analysis of private insurance, uninsured rates, Medicare, and 
Medicaid.  
Research Questions and Hypotheses 
The research questions (RQs) and hypotheses were as follows: 
RQ 1. What is the difference, if any, between hospital CHF readmission rates for 
Blacks, non-Hispanic and Whites, non-Hispanic in California?  
H11 (Alternative Hypothesis): There is a statistically significant difference 
between hospital CHF readmission rates for Blacks, non-Hispanic, and Whites, 
non-Hispanic in California. 
H01 (Null Hypothesis): There is not a statistically significant difference between 
hospital CHF readmission rates for Blacks, non-Hispanic, and Whites, non-
Hispanic in California. 
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RQ 2: What is the difference, if any, between hospital CHF readmission insurance 
reimbursement for Blacks, non-Hispanic and Whites, non-Hispanic in California? 
H12 (Alternative Hypothesis): There is a statistically significant difference 
between hospital CHF readmission insurance reimbursement for Blacks, non-
Hispanic and Whites, non-Hispanic in California. 
H02 (Null Hypothesis): There is not a statistically significant difference between 
hospital CHF readmission insurance reimbursement for Blacks, non-Hispanic and 
Whites, non-Hispanic in California. 
Theoretical Foundation for the Study 
The theoretical framework for this study was Bandura’s (1986) social cognitive 
theory (SCT). Bandura developed social learning theory in the 1960s and expanded its 
key concepts into SCT in 1986 (Bandura, 1986). This theory has been used extensively in 
healthcare communication as it pertains to the modeling of behaviors and improvements 
in processes (Pajares, Prestin, Chen, & Nabi, 2009). A tenet of SCT is that past 
experiences influence reinforcement, expectations, and perceived self-efficacy in patients 
(Hoffman, 2016). As such, researchers consider a person’s past experiences and assess 
the factors that may lead a person to take a certain action (Hoffman, 2016). SCT 
emphasizes that when administrators and staff work together to achieve common goals, 
they can make a positive difference in behaviors (Pajares et al., 2009).  SCT also provides 
a framework for designing, implementing, and evaluating programs, which could be used 
to facilitate and improve care for Black, non-Hispanic CHF patients (Jeihooni, Hidarnia, 
Kaveh, Hajizadeh, & Askari, 2016). SCT can be used to understand the circumstances in 
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which people acquire and maintain specific behavioral patterns while establishing a 
process for intervention (Dybowski, Sehner, & Harendza, 2017). 
Self-efficacy, as a construct of SCT, influences the effort one puts forth to change 
risk behavior and the persistence to continue striving despite barriers and setbacks that 
may undermine motivation (Hoffman, 2016). Although self-efficacy is directly related to 
health behavior, it also affects health behaviors indirectly through its impact on goals 
(Dybowski, Sehner, & Harendza, 2017). The importance of self-efficacy is that it can 
influence how people perceive and embrace change.  The more healthcare leaders can 
educate and promote health outcome improvements, the greater the likelihood CHF 
patient perceptions about self-efficacy will produce desirable results (Bandura, 1997, 
2001). 
Nature of the Study 
This study involved secondary analysis of data. I statistically analyzed the 
differences of the variables and determined significance by using a t-test and Levene’s 
test for equality of variances. The dependent variable for this study was CHF readmission 
rates for non-Hispanic Black and White patients in California.  The independent variable 
was insurance reimbursement rates for non-Hispanic Black and White CHF patients in 
California. Insurance reimbursement included an analysis of private insurance, uninsured 
rates, Medicare, and Medicaid.  
The secondary data collection involved downloading readmission discharge data 
from the Office of Statewide Health Planning and Development (OSHPD) for the 
calendar years 2014-2016 and State Inpatient Databases (SID) for the calendar years 
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2014- 2016 from the Healthcare Cost and Utilization Project (HCUP). Using the provider 
report from the Centers for Medicare & Medicaid Services (CMS), I was able to examine 
the following explanatory variables: Diagnosis-related group, provider ID, provider zip 
code, total discharged, average covered charges, average total reimbursements, average 
Medicare reimbursements, average Medicaid reimbursements, average private insurance 
reimbursements, average uninsured private pay reimbursements, age (mean), and break-
out. The variables for insurance reimbursement were categorized as follows: average 
Medicare payment, average Medicaid payment, average private insurance payment, and 
average uninsured private payment (HCUP, 2016; OSHPD, 2016). Probability sampling 
was used as the sampling strategy for this study. 
Literature Search Strategy 
 To better understand the increasing number of CHF readmissions, I used several 
databases to retrieve the most current literature on CHF, readmissions, and utilization 
cost. These articles identified CHF as the leading cause of rehospitalization and also 
showed that the uninsured with CHF have poorer health outcomes and a higher rate of 
hospital readmissions (Whitworth, 2018). Database searches were my primary means of 
finding articles related to this study and gaining an understanding of the research 
questions’ strengths and weaknesses. The following Walden University databases and 
search engines were used to conduct a systematic literature review on adults aged 18-64: 
CINAHL Plus, PubMed, Ovid MEDLINE, Medline, Cochrane, ProQuest, and Google 
Search. I focused my search on scholarly journals and articles published in English from 
2013 to 2018. In addition, I searched for literature on organizational and governmental 
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websites, including AHA.com. CDC.gov, HCUP.ca.gov, Ache.net, minority 
health.hhs.gov, ahrq.gov, healthypeople.gov, icpsr.umich.edu, and ncbi.nlm.nih.gov. The 
key search terms were readmission, Blacks with CHF, heart failure, congestive heart 
failure, chronic disease, rehospitalization, and insurance reimbursement.  
Literature Review Related to Key Variables and/or Concepts 
The purpose of this literature review was to synthesize studies completed by 
researchers about hospital readmission rates (dependent variable) for Black, non-
Hispanic, and Whites, non-Hispanic patients with CHF, and differences with insurance 
coverage and insurance reimbursement rates (independent variables). CHF is an ongoing 
health problem, and research has shown that it is the leading cause of death in the United 
States (Pandey et al., 2016). Mantel (2015) reported that CHF remains the leading cause 
of early hospital readmission among adults aged 18-64 within 30 days of the first 
hospitalization. Due to the increase in hospital readmission rates, health care spending 
continues to rise among all payer types and threatens the health care delivery system if 
substantial changes are not made to prevent avoidable readmissions (Blumenthal et al., 
2015). As Islam, O’Connell, and Lakhan (2017) noted, researchers have reviewed 
hospital readmissions, chronic disease management, and CHF to establish some of the 
contributing factors associated with hospital readmissions. I review some of these factors 
in this literature review. 
Hospital Readmission Variable 
Financial implications. CHF is an escalating health problem in the United States 
and the highest cause of death among the racial/ethnic group Blacks, non-Hispanic 
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(Fleming, 2018).  CHF was responsible for an enormous amount of healthcare burden 
and financial struggle in the United States (Mirkin, Enomoto, Caputo, & Hollenbeak, 
2017).  According to Mirkin et al. (2017), CHF was the most frequent cause of hospital 
readmissions in adults aged 18-64. The authors found that there has been an insignificant 
amount of consistency in the variables used to predict readmission criteria. Even though 
the authors used predictive and statistical methods to analyze readmission risk factors, 
they concluded that there is no magical technique to highlight a better readmission tool to 
identify those risk factors associated with hospital readmission. As a result, Mirkin et al. 
argued that experts had recommended a risk prediction model encompassing not only the 
patient’s condition but also the hospital system and provider approach for determining 
patients with higher risk.   
Bayati et al. (2016) had similar views about the cost-effectiveness of readmissions 
that posed a considerable cost burden in the US. The authors stated that rehospitalization 
had been a primary contributor to the 10 billion per year deficit in healthcare expenditure 
of CHF patients. The authors also found that 47% of the readmissions that occurred 
within 30 days in the Veteran Health Administrations Hospital (VA) was a result of 
congestive heart failure. Congestive heart failure is an ongoing health problem in the US, 
with a financial impact on the overall cost of health care. 
Similarly, Boesen, Leal, Sheehan, and Sobolik (2015) noted that societal and 
healthcare issues are predictors of financial implications for readmission. The study 
found that CHF patients discharged home without proper discharge information have 
shown to be a contributing factor for hospital readmissions. Bayati et al. (2016); Boesen, 
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Leal, Sheehan, and Sobolik (2015); and Mirkin et al. (2017) stated that, as a result, the 
financial implications in the health care system had opened avenues for researchers to use 
predictive models to identify CHF patients with the highest risk factor for readmission. 
Improper discharge process. There have been studies that examine the discharge 
process as a contributing factor of hospital readmissions for Blacks, non-Hispanic CHF 
patients. Feltner et al. (2014) surveyed readmissions and discharge processes and found 
little evidence that indicated reduced readmissions due to the discharge process for CHF 
patients. Also, the researchers found that home visit programs, telemonitoring, and nurse-
led programs did not reduce the risk of heart failure readmissions. For these reasons, 
Feltner et al. concluded that some of their research directed toward hospital readmissions 
yielded results without methodological limitations or direction. Therefore, they surmised 
that further research is needed to evaluate the improper discharge process and risk 
indicators associated with CHF readmission.  
Importantly, the increase in hospital readmission rates is causing healthcare 
leaders to look for ways to minimize readmissions. Healthcare leaders are employing the 
technique of placing patients into observation status instead of admitting them into the 
hospital to reduce readmission penalties (Kaiser Family Foundation, 2015). 
Unfortunately, observation status creates other problems concerning readiness for 
discharge, patient education, and the dilemma that occurs when a nursing home bed is 
needed.  Therefore the implications of reporting readmissions are changing the healthcare 
delivery system, which confuses patients, families, physicians, and hospital staff (Kim, 
Mortensen, & Eldridge, 2015).   
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In summary, the increase in the financial penalty for having high readmission 
rates is creating a sense of urgency within health care systems. Even though preventing 
rehospitalization is a complex issue that encourages providers and health care leaders to 
engage in new healthcare delivery models to deliver improved patient outcomes and 
lower the cost of care. Healthcare leaders are encouraged to develop tools that will 
empower patients to protect and improve their health. 
Insurance Reimbursement Variable 
Reimbursement incentives to reduce readmissions. In response to the health 
care cost increases, insurance providers have developed an array of strategies to control 
cost for those they insure including transferring cost to their health plan members and 
adding an administrative mechanism to identify and discourage inappropriate care by 
penalizing hospitals with higher readmission rates (Erdem et al., 2016). 
The PPACA began the next significant and recent shift in reimbursement 
consideration in health care (Singer, 2017).  According to Blumenthal, Abrams, and 
Nuzum (2015), the PPACA embraced efforts to move from volume-based fee-for-service 
reimbursement towards performance-based, and this impacted many hospitals negatively 
due to higher readmission rates which subjected hospitals to financial penalties. 
Bosko, Dubow, and Koenig (2016); Bowling, Newman, White, and Wood (2017) 
argued that one goal of the PPACA is to ensure access to health care while also 
containing costs through cost-shifting to outpatient service provisions.  Policies and 
legislative principles that led to the implementation of all-payer systems including rate 
setting, cost control, equity, access, solvency, and adequate care provision are explored 
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throughout the literature (Bosko, Dubow, & Koenig, 2016; Bowling, Newman, White, & 
Wood, 2017).   Payment strategies and incentives are vital tools for the success of the 
PPACA (Gilman et al., 2015).  The PPACA includes insurance reimbursement strategies 
such as bundled payments, pay-for-performance, and value-based purchasing, which have 
been implemented in various states and supported by the federal government.  
Reimbursement strategies must reward provider collaboration, patient-focused care, and 
high-quality care with financial incentives to address care cost growth (Gilman et al., 
2015). Incentives such as cost-sharing and rewards based on established goal 
achievement remain at the forefront of the ACA's strategy to shape provider behaviors to 
reduce costs and improve care quality (Bosko et al., 2016).   The following sections 
provide additional information about these different insurance reimbursement strategies. 
Bundled payments. According to CMS (2017), payers will increasingly seek to 
move the financial risk of managing patients to providers through strategies such as 
bundled payments and capitation. Bundled payments include all fees for a procedure in 
one billing process rather than separating them. The bundled payment creates incentives 
for hospitals and physician offices to coordinate patient care and reduce duplicative or 
unnecessary services while emphasizing the need to minimize hospital readmissions 
(CMS, 2018).  
According to Sanghavi et al. (2015), providers view the bundled payment 
reimbursement strategy as an opportunity to advance from a compliance-driven culture to 
one of collaboration among providers and innovation to reduce health care costs and 
improve care quality to patients.  Valania and Slawsky (2017) suggested that providers 
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are incentivized to lower costs through improved care coordination and quality 
improvement while focusing on decreased utilization of costly hospital readmissions. 
Bowling et al. (2017), on the other hand, stated that some hospitals view bundling as a 
way to reduce provider control over practice decisions. Another strategy for cost control 
and collaboration incentive is pay-for-performance. 
Pay-for-performance: Incentives to decrease hospital readmissions. CMS 
(2018) officials have created and implemented a payment model with goals that 
emphasize reductions in cost and improvements in quality.  This program incentivizes 
and rewards hospitals and providers that meet the goals, which include targets for 
decreasing readmissions (CMS, 2018). Caveney (2016, p. 265) stated that pay-for-
performance reimbursement methods are based on quality, utilization, and patient 
satisfaction along the care continuum.  High performing organizations and providers are 
also rewarded with a high volume and loyal patient base adding to the organization's 
financial solvency. Caveney went further to say that this mechanism of payment was 
developed by private and public payers to force hospitals to close the gap on higher 
readmission rates and improve the quality of care. Financial incentives are a strong 
intrinsic motivation for organizations to provide high-quality care, according to CMS 
(2015). Therefore, if organizations achieve the CMS pay-for-performance identified 
metrics, the organizations receive financial incentives and high levels of patient, 
community, and payer trust (Ayanian & Markel, 2016).   
Achievement of performance metrics such as decreased hospital readmission rates 
– plus high performance on quality care, patient satisfaction, and ranking results 
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compared to other hospitals results in the positive market competition by establishing 
high and low performers (Bowling, Newman, White, & Wood, 2017). Baicker (2015) 
stated that 90% of these have programs are geared toward physician incentives, whereas 
only 38% of incentives are geared toward acute care facilities. Another strategy that is 
shown to contain cost and improve quality of care while penalizing hospitals for higher 
readmissions is value-based purchasing.  
Value-based purchasing: Rewards for decreased readmissions. Another CMS 
incentive program is Value-Based Purchasing, which is promoted by the PPACA and 
rewards providers and hospitals who emphasize value-based care rather than volume care 
and quality care rather than quantity care (Jacobson, 2016). As a result, Heidenreich et al. 
(2016), indicated that hospitals with fewer readmissions and high-quality outcomes are 
eligible to receive financial rewards.  The United States Department of Health and 
Human Services (DHHS) (2011a) reported that an estimated 850 million dollars were 
earmarked for hospitals achieving star ratings due to established goals on performance 
measures, clinical indicators, and patient satisfaction.  Jacobson (2016) indicated that 
value-based purchasing approaches include service integration, payment strategies, and 
value-based insurance design are emphasized in national health care reform legislation.   
Uninsured variable, a contributing factor to hospital readmissions. The 
comprehensive research conducted by Elixhauser and Steiner (2016) highlighted all-
payer, all-cause hospital readmissions. The authors found that most readmissions are the 
result of chronic conditions and uninsured patients with limited access to healthcare. CHF 
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is known to be one of the highest common chronic diseases that result in patients 
readmission within eight to thirty days.  
Boesen, Leal, Sheehan, and Sobolik (2015) had similar findings of the causes of 
readmissions and revealed that due to the complexities of hospital readmissions, all areas 
of a health care system must be targeted. The authors also indicated that creating a 
healthcare communications system and looking for ways to connect the uninsured with 
insurance will reduce all-causes of readmissions. Similarly, Wang, Shi, Nie, and Zhu 
(2015) found that uninsured adults were less likely to obtain preventive care and keep 
their physician appointments. Furthermore, the uninsured population was significantly 
more likely to have no primary care physician and had difficulties getting attention. The 
authors also indicated that blacks with CHF reported an inability to get medical care 
through the typical health care delivery system. As a result, they sought treatment in the 
emergency room.   Also, they suggested that uninsured patients lacked access to care – 
both preventive services and treatments - even though studies have shown that uninsured 
patients, on average, received 55% of medical services (Wang et al., 2015). 
Wang et al. (2015) also stated that income and socioeconomic factors were found 
to be a significant contributor to readmissions. Their research results suggested that even 
though there were other contributing factors, a lack of insurance was found to be the most 
critical factor associated with significant readmissions. The authors indicated that one of 
the main goals of the PPACA is to promote universal health coverage by expanding the 
State Health Insurance Exchange marketplace. Research has shown that even with the 
expansion of the Medi-Cal program in California, ethnicity, socioeconomic status, and 
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place of residence are predictors of readmission risk and readmissions (Betancourt, Tan-
McGrory, & Kenst, 2015). Research indicates that uninsured patients with CHF have a 
higher risk of hospital readmission. Boesen, Lead, Sheehan, and Sobolik (2015); 
Elixhauser and Steiner (2016) agreed that because CHF is the number one cause of 
hospital readmission in the U.S, more research is needed to develop a better delivery 
model that will improve access to care, improve patient’s outcome, and lower cost.   
Uninsured patients and CHF. Heart failure patients, especially Blacks, non-
Hispanic, have high rates of hospital readmission (Sharma, Colvin-Adams, & Yancy, 
2016). The authors stated in 40,000 patients with heart failure that education, lower-
income, and lack of insurance were significant predictors of hospital readmission. These 
socioeconomic factors could account for the delay of inadequate access to health care and 
noncompliance with follow-up appointments. The study points to sociodemographic 
factors such as sex, age, race/ethnicity, and insurance. As a result, studies have shown 
that an increased risk of hospital readmission rates is associated with sociodemographic 
factors. Even though Kirby and Kaneda (2016) argued that current research offers a 
limited description of the complex health coverage and hospital readmission, especially 
for Blacks, non-Hispanic in the United States, the individuals in these health categories 
are more likely to require medical care than their white counterpart. The insurance gap 
between white and black is more severe than indicated in previous surveys (Noori et al., 
2015).  
Furthermore, Kirby and Kaneda (2017) stated that research does not provide 
adequate information about the uninsured population, even though many adults aged 18-
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64 do not have access to health care or employer-sponsored programs. Healthcare leaders 
are focusing on driving the patchwork of public programs that are available to educate 
these populations rather than providing a long-term solution.  
 Conversely, Martinez et al. (2015) stated that even though adults aged 18-64 
could still buy private health insurance plans through the Insurance Marketplace or state-
based exchanges as part of the Affordable Care Art of 2010, low-income and 
socioeconomic factors highlight unplanned hospital-based care among younger patients. 
Black and Schiller (2016) mentioned that the utilization measures among adults aged 18-
64 who are uninsured with CHF differ from state to state. Kim, Mortensen, and Eldridge 
(2015) similarly argued that to link low-income uninsured patients with primary care 
physicians who could reduce emergency or hospital readmissions is problematic because 
most physicians request payment at the time services are provided.  
A study conducted by Clarks and Schiller (2016) found that adults ages 18-64 
without health insurance coverage neglect seeking healthcare services. The study showed 
that even though the percentage of uninsured adults at the time of the interview decreased 
from 16.0% in 2010 to 9.0% in 2016, readmissions for CHF remained significant at state 
and federal levels.  Ayanian et al. (2015) conducted a similar study on readmissions. This 
study showed compelling evidence of the adverse clinical consequences of being 
uninsured. Furthermore, the study also examined the type of care received by uninsured 
patients with CHF and chronic conditions. The authors found that the quality of care 
received by uninsured adults with a low income was substandard and substantially worse 
when compared to insured low-income adults, thereby increasing the risk for 
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rehospitalization. Even though the government has begun to extend affordable health 
insurance to the uninsured, Ayanian et al. (2015) argues that the unmet health needs of 33 
million uninsured adults continue to fester in the health care delivery system without a 
cohesive political response to minimize avoidable readmissions. 
Causes for hospital readmission. Congestive heart failure is a debilitating 
condition associated with frequent readmissions. A considerable amount of research has 
revealed that 25-60% of readmissions occur within six months of discharge, and these 
readmissions are due to a variety of reasons. Noori et al. (2015) concluded there is a 
correlation between socioeconomic factors and CHF, which include income and 
education as primary risk factors for rehospitalization due to CHF. Also, Noori et al. 
identified that these variables - lower educational level, lower-income, and lower job 
levels - were shown to cause higher readmission rates even though other variables such as 
inadequate physical activity and hypertension were also found to be independent 
predictors for readmission. Martsolf et al. (2016) found that the implication for 
readmission and insurance reimbursement policy could be affected in two ways: Firstly, 
lower-income and educational levels of patients affect readmission rates for a substantial 
proportion of hospitals.  The financial impact is enormous, and it could be advantageous 
to consider this information as opposed to not adding this information to algorithms that 
consider overall risk adjustment for readmissions. Secondly, the study also demonstrated 
that most of the hospital readmissions were affected by race/ethnicity and socioeconomic 
factors that are consistent with previous studies.  
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Also, Heidenreich et al. (2016) indicated that the cost of CHF readmissions is 
expensive and will remain a substantial concern for health care providers if better efforts 
are not put in place to reduce the number of patients developing CHF. Most importantly, 
techniques and strategies to prevent CHF readmissions and improve efficiency are 
needed to decrease hospital readmissions. The authors also emphasized that the burden of 
CHF hospital readmissions will increase in the next 18 years if the current approach or 
delivery system is not improved.  
A comprehensive study conducted by Basu, Hanchate, and Bierman (2018) 
showed that readmission rates could be affected by different insurance reimbursement 
rates. Black CHF patients had the highest risk of readmission compared to white CHF 
patients when covered by low reimbursement insurance, such as Med-Cal. Having no 
insurance was uniformly associated with a higher rate of readmissions in blacks that may 
reflect no access to healthcare or suboptimal outcomes. This study is consistent with 
work done by Martsolf et al. (2016).  Accordingly, Martsolf et al. found that blacks are 
susceptible to hospital readmissions within nine days after being discharged. As a result, 
the result of the studies had several strengths, including multilevel framework and state-
level focus on sociodemographic composition, including patients aged 18-64 and aged 65 
and older. However, the findings of this study may have some useful implications for 
states expanding on Medicaid coverage. In conclusion, further studies should investigate 




To summarize, CHF hospitalizations and readmissions have been reported as 
common in black patients due to insurance restrictions or the inability to pay for medical 
care (HHS, 2017). Blacks are more likely to be under age 65 with limited financial 
resources and poorer health status, increasing the frequency of rehospitalization. 
Uninsured CHF patients were much less likely than insured adults to have received 
routine checkups during which any health risk might have had a different outcome. 
Research Gap 
I used a systematic approach to choose studies that fulfilled the research goals of 
this correlational study and address the gap concerning healthcare access for non-
Hispanic Black and White patients with CHF in relation to hospital readmissions.  The 
chosen studies present comprehensive information about the topics.  In particular, this 
concerned the strengths of the studies conducted by researchers and whether the results 
and conclusions provided a consistent approach to the topics.  
Overall, I observed that the chosen studies support the need for more research to 
address the gap associated with the causes of healthcare access and to add to the body of 
knowledge that could improve wellness and reduce hospital readmissions for Black, non-
Hispanics.  For example, Kim, Mortensen, and Eldrige (2015, p. 798) stated that their 
goal was to analyze the efficacy of interventions that address the influx of uninsured CHF 
patients to the emergency department by using the CMS collaborative efforts of 2010 
with local clinics and hospitals. Their findings were consistent with other research.  
Martinez, Ward, and Adams (2015) completed a comparative analysis on 
uninsured patients readmitted with CHF from 2013-2014 to see if there were any changes 
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for adults aged 18-64.  Blacks, non-Hispanic with CHF readmissions decreased from 
24% to 17.6% due to the Affordable Care Act that provided access to private health 
insurance through the Health Insurance Marketplace. However, medical care for Blacks 
did not have any significant changes as compared to non-Hispanic Whites. 
Ayanian, Weissman, Schneider, Ginsburg, and Zaslavsky (2015) completed a 
study about long-term uninsured patients ages 18-64 with chronic conditions, and results 
indicated that these patients encountered barriers to preventive services. These barriers 
increased the level of hospital readmissions for patients with CHF. The study variables 
are somewhat consistent with this study and focused on sex, age, race/ethnicity, income, 
education, and employment. 
Conclusion 
Black, non-Hispanic patients with CHF, are at a significantly higher risk for 
hospital readmissions as compared to their white counterparts (Carnethon et al., 2017). 
This high rate of hospital readmissions is causing a financial burden for patients, 
hospitals, and healthcare providers. The high rehospitalization rates have prompted many 
healthcare leaders and providers to create an adaptive health care delivery system to 
provide tools to manage chronic conditions at home to reduce rehospitalization (Sharma 
et al., 2016). Hospital Administrators are presented with greater responsibilities to 
develop tools and methods to reduce readmissions and also to accurately identify high-
risk CHF patients effectively. However, like many such studies mentioned above, Black 
patients with CHF have been reported to have the highest number of hospital 
readmissions due to insurance restrictions that prevent them from having primary care 
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physicians to facilitate preventive care (Bergethon et al., 2017). Attention should be 
focused on a patient’s socioeconomic status as discharge plans are developed, which may 
enable identification of those at highest risk of readmission. Given the cost and quality 
implications of these findings, addressing readmissions while caring for an increasingly 
diverse population has become a significant concern for hospital administrators and 
health care leaders (Swayne, Duncan, & Ginter, 2017).    
Definitions 
30-day readmission: An admission to an acute care hospital within 30 days of 
discharge from the same or another acute care hospital with risk-standardized 
readmission measures, which includes all-cause unplanned readmission (Elixhauser & 
Steiner, 2015). 
Access to care: The availability of services and barriers to access, utilization, and 
outcomes of health needs, materials and cultural settings of diverse groups in society 
(Agency for Healthcare Research and Quality, 2015)  
Congestive heart failure (CHF): A progressive disease that affects the pumping 
power of the heart muscles.  CHF also refers to a stage in which fluid builds up around 
the heart and causes it to pump inefficiently and get worse over time (Whitworth, 2018). 
Coordination of care: Any activity that helps ensure that a patient’s needs and 
preferences for health services are met.  Coordination of care encompasses information 
sharing across interdisciplinary teams to facilitate the appropriate delivery of health care 
services (Agency for Healthcare Research and Quality, 2016).   
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Rehospitalization: A term that is used interchangeably with readmissions, 
meaning a return to an acute care hospital after discharge (Islam et al., 2017). 
Socioeconomic status: The social standing or class of an individual or group. It is 
often measured as a combination of education, income, and occupation. Examinations of 
socioeconomic status often reveal inequities in access to resources, plus issues related to 
privilege, power, and control (Noori et al., 2016).  
Transition of care: The movement of a patient from one care setting to another 
(CMS Incentive Program, 2016). 
Assumptions 
There were assumptions made for this study; the researchers for OSHPD, the 
primary data company, assumed that all self-reported information provided by the 
research participants was truthful and reliable. This assumption is taken into 
consideration because the consent form delivered to the participants indicated that their 
identity was concealed, and OSHPD preserves confidentiality.  Furthermore, the 
participant's rehospitalization experience and situation were assumed to be quantifiable 
and generalizable to similar ethnic groups.  
Limitations 
The following limitations of this study are (a) the use of small study sample, 
whereas a larger sample size is desired to enhance methodology and data analysis options 
and more reliable to reflect the population means. (b) The study focused on participants 
who utilized English (written and verbal) as their primary language, provision of a 
translator and translated materials may have allowed for a more culturally and ethnically 
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diverse study sample. (c) The period of the data used for this study was only between 
2014, 2015, and 2016. A three-year period may not ensure an adequate sample size. (d) 
Since data from only one state was utilized, determining all-cause readmissions limited 
generalizability to different patient populations in the US. The data was collected in 
California, and other states may have had different results. (e) Further limitations 
included the possibility of sampling and coding errors, misclassified variables, and the 
difficulty in accurately obtaining readmission data for Blacks, non-Hispanics, and other 
ethnicities.  
Scope and Delimitations 
Generalizability 
The generalizability of this study was limited to non-Hispanic Black and White 
CHF patients in California. Gender, age, and income were not considered for this study 
and were not included in the secondary data. The secondary data was obtained from the 
Office of Statewide Health Planning and Development (OSHPD) for the calendar year 
2014-2016 and State Inpatient Databases (SID) for the calendar year 2014-2016 from 
Healthcare Cost and Utilization Project (HCUP).  It was determined that this data met the 
qualifications for inclusion in the study.  A multiplicity of factors influences patients' 
readmissions, the purpose of researching in this field, and trying to control confounding 
variables is a complex undertaken.  
Internal Validity 
For this study, participants were selected with certain characteristics that could 
predispose them to have certain outcomes. For example, this study uses CHF as the only 
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diagnosis. Access to care and conditions of severity are highly subjective between 
patients. Internal validity can be minimized by taking preventive action to adhere closely 
to the scope of the study (Trochim, Donnelly, & Arora, 2016, p. 217).   
External Validity 
The threat of interactive effects of experimental arrangement may arise when 
results are generalized beyond the racial groups or social groups not included in this 
study. Also, OSHPD, the primary data source for this study, collects data from hospitals 
which may use different approaches when identifying the readmission process. This 
threat may narrow the characteristics of participants in the study (Creswell, 2009).  
The purpose of this study is to examine the differences between hospital 
readmission rates and insurance reimbursement rates for non-Hispanic Black and White 
patients with CHF. Studies have shown that there may be no significant follow up for 
Black patients with their primary care physician after hospital discharge.  When 
involving the executive leadership team in the patient readmission process, it is necessary 
to use clear metrics in order to determine progress and guide necessary insurance 
adjustments to monitor and execute vision and strategy for setting and achieving patient 
goals (Wei et al., 2018).    
The importance of access to health care in order to decrease readmissions cannot 
be overemphasized. As a result, hospital administrators are focusing on efforts to improve 
the quality of care and reduce spending on readmissions under the provision of the 
PPACA (Erdem et al., 2015). This study will use bivariate analysis to infer and evaluate 




This study addressed the research gap concerning insurance coverage and 
insurance reimbursement rates associated with readmissions for non-Hispanic Black and 
White CHF patients (Levesque, Harris, & Russell, 2015).  A significant aspect of this 
study is the potential to provide healthcare administrators with information about Black, 
non-Hispanic readmission rates in relation to the lack of insurance and access to 
healthcare and develop ways to change these outcomes. The Social Cognitive Theory 
provided the framework for this study as a construct for understanding how the past may 
inform and improve the future (Hoffman, 2016). 
Significance for Positive Social Change 
The study was designed to examine the differences between hospital readmission 
rates and insurance reimbursement rates for non-Hispanic Black and White CHF patients 
in California.  Even though there is a plethora of research on CHF, there is a gap in the 
literature comparing these two populations and whether there needs to be more attention 
paid to the reasons Black patients are readmitted more often than White patients  
(Boesen, Leal, Sheehan, & Sobolik, 2015; Jeihooni et al.; Levesque, Harris, & Russell, 
2015). Black patients have the highest uninsured rates, which consequently increases the 
CHF hospital readmission rates (Jeihooni et al., 2016). The high clinical and financial 
burden of this condition, especially among young and older adults, has led to an interest 
by hospital administrators to improve outcomes and decrease the cost of care (Sharma et 
al., 2016).  
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Significance for Positive Leadership Change 
Furthermore, improving interdisciplinary communication and adopting high-
reliability principles to achieve safety, better patient outcomes, and improvements in 
medical excellence could reduce readmissions in the future. This study could provide 
healthcare administrators with information about Blacks, non-Hispanic readmission 
utilization rates in relation to the lack of insurance and access to healthcare as compared 
to their White counterparts.  By improving administrators’ awareness of the differences 
and reasons for readmissions, health education programs and strategies could be 
developed that would help Black patients and others with CHF learn how to minimize 
hospital readmissions and emergency room visits (Sharma et al., 2014; Wagner et al., 
2017, p. 7).  
Summary and Conclusions 
Many studies in Section 1 demonstrated how important it is for health care leaders 
to develop strategies that could decrease hospital readmissions rates.  Most readmissions 
are a result of chronic conditions and uninsured patients with limited access to healthcare. 
CHF is one of the most common chronic diseases, and patients are frequently readmitted 
within eight to thirty days after their initial discharge. Studies also focused on creating 
healthcare communication systems that encourage staff and patients to develop a better 
understanding of health behaviors, financial issues, and insurance coverage as essential 
factors that impact hospital readmissions – either positively or negatively. The hospitals 
with higher rates of readmissions face reductions in payment and scrutiny from the 
insurance companies. Hospital administrators have a responsibility to develop tools and 
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methods to reduce readmissions and also to accurately identify high-risk CHF patients 
that would benefit from more effective interventions. 
Section 1 explored the focus of this study on differences in readmission and 
reimbursement rates for non-Hispanic Black and White CHF patients. Many studies were 
identified that relate to the problem, purpose, and variables of this study.  Next, Section 2 




Section 2: Research Design and Data Collection 
Introduction    
The purpose of this study was to examine the differences, if any, between non-
Hispanic Black and White CHF patients concerning hospital readmission rates and 
insurance reimbursement rates.  Studies have shown that there is no significant follow-up 
for Black patients with their primary care physicians after hospital discharge (Betancourt 
et al., 2015). Research on causes for CHF readmissions could improve health system 
protocols and enhance access to healthcare by encouraging Black patients with CHF to 
follow up with their primary care physician after hospital discharge. Involving the 
executive leadership team in the patient readmission process using clear metrics allows 
healthcare administrators to explore necessary adjustments and execute strategies for 
setting and achieving patient goals (Wei et al., 2018). 
The importance of access to healthcare is essential for positive health outcomes. 
As a result, hospital administrators are focusing on efforts to improve the quality of care 
and reduce spending on readmission under the provisions of the PPACA (Erdem et al., 
2014). For this study, I used a t-test analysis to infer the statistically significant 
differences between hospital readmission rates and insurance reimbursement rates for 
Blacks, non-Hispanic, and Whites, non-Hispanics CHF patients. 
Research Design and Rationale 
Research Design 
A quantitative correlational study involves converting data to a numerical form 
that can be subjected to a statistical analysis via SPSS or other programs to investigate 
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the relationship between variables (Babbie, 2015, p. 423). Variables are logical sets of 
attributes; they are measured using analytical instruments to determine values (Frankfort-
Nachmias & Leon-Guerrero, 2015).  The differences between readmission rates and 
insurance reimbursement rates for non-Hispanic Black and White CHF patients were the 
focus of the statistical examination in this study. In order to determine the relationship 
between the independent and dependent variables, I used a correlational design.  
Variables 
In this study, I analyzed two independent variables and one dependent variable. 
The dependent variable for this study was CHF readmission rates for non-Hispanic Black 
and White patients in California.  The independent variable was insurance reimbursement 
rates for non-Hispanic Black and White CHF patients in California. Insurance 
reimbursement included an analysis of average private insurance reimbursements, 
average uninsured private pay reimbursements, Medicare, and Medicaid. Correlational 
research is useful for measuring the strength of a linear relationship (Creswell, 2009). As 
part of my correlational analysis, I compared the dependent variable separately with each 
of the independent variables to determine the differences. 
By using a correlational design and secondary data, I encountered no resource 
constraints for this study nor any anticipated delays. The recruitment of participants was 
not applicable for data collection purposes. Also, the secondary data set was obtainable 
more quickly than primary data, and it provided the basis for data comparison.  
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Methodology   
In this section, I will cover the population of the study, sampling, the data 
collection process, power analysis, sample size estimation, and the data analysis plan. 
Population 
The target population for this study was non-Hispanic Black and White CHF 
patients ages 18-64 living in California. According to Black and Schiller (2015), many 
Black patients have limited access to health care and may have no insurance coverage. In 
addition, this racial-ethnic group has the highest number of hospital readmissions in the 
United States (Basu, Hanchate, & Bierman, 2018). In order to generalize the study 
findings, I included in the study group, all possible sampling units that represented the 
population, as per Frankfort-Nachmias & Leon-Guerrero (2015).  
Sampling and Sampling Procedures 
 I used probability sampling as the sampling strategy for this study. Probability 
sampling was used because of the larger study population. The specific sampling design 
for this study was stratified random sampling (Frankfort-Nachmias & Leon-Guerrero, 
2015, p. 207). I selected acute care hospitals and emergency room sampling units based 
on predetermined parameters that included Black, non-Hispanic and White non-Hispanic 
patients. Additionally, the sample population included participants who were private pay, 
uninsured, or Medicaid beneficiaries. Probability analysis helps create an accurate 
selection of the study population, and researchers can use other statistical methods to 
determine the precise sample size (Babbie, 2015).   
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I did not consider cluster random or systematic sampling design appropriate for 
this study. Cluster random is suitable only when participants are geographically spread 
out to other states (Frankfort-Nachmias & Leon-Guerrero, 2015). In this study, I 
excluded Black patients with CHF from other states and focused only on Black patients 
with CHF in California. Nonprobability sampling designs, such as purposive sampling, 
also would not have been appropriate for this study. This is because the sampling units 
would have predetermined parameters due to a small sample size that allows all groups to 
be inclusive in the survey (see Frankfort-Nachmias & Leon-Guerrero, 2015). 
Sample size estimation. I calculated the required sample size estimation using 
G*Power software. A t-test was selected, and the correlational point biserial model 
statistical test was selected using the G*Power software. A priori power analysis was 
conducted to determine the necessary sample size needed to run a correlation analysis 
between the variables of CHF readmission rates and insurance reimbursement rates. The 
results of the analysis indicated that a sample size of 305 was sufficient to detect a 
significant correlation with a medium effect size with a power of .90 and an alpha of .05.   
Data Analysis Plan 
I obtained the data set used for this study from the OSHPD. The data set is an 
aggregated data set collected and coded in Excel. Because of the use of secondary data, 
no individual or organization participated in this study. The statistical technique was a t-
test, which is the analysis of variance to test for differences between groups.  
I downloaded and stored the nonconfidential data set on my hard drive. 
Additionally, standard descriptive statistics for each variable were performed. Means, 
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standard deviations, and tests of normality for each variable were run using SPSS. 
Furthermore, means and standard deviations for each group within the respective 
categorical variables were analyzed. The RQs and hypotheses were as follows: 
RQ 1. What is the difference, if any, between hospital CHF readmission rates for 
Blacks, non-Hispanic and Whites, non-Hispanic in California?  
H11: There is a statistically significant difference between hospital CHF 
readmission rates for Blacks, non-Hispanic, and Whites, non-Hispanic in 
California. 
H01: There is not a statistically significant difference between hospital CHF 
readmission rates for Blacks, non-Hispanic, and Whites, non-Hispanic in 
California. 
RQ 2: What is the difference, if any, between hospital CHF readmission insurance 
reimbursement for Blacks, non-Hispanic and Whites, non-Hispanic in California? 
H12: There is a statistically significant difference between hospital CHF 
readmission insurance reimbursement for Blacks, non-Hispanic and Whites, non-
Hispanic in California. 
H02: There is not a statistically significant difference between hospital CHF 
readmission insurance reimbursement for Blacks, non-Hispanic and Whites, non-
Hispanic in California. 
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Threats to Validity 
External Validity 
An essential aspect of this study involved the evaluation of threats to external 
validity, which may occur when incorrect inference from sample data is drawn (Creswell, 
2009). The threat of interactive effects of experimental arrangement may arise when 
results are generalized beyond the racial groups or social groups not included in this 
study. Also, OSHPD, the primary data source for this study, collects data from hospitals 
that may use different approaches when identifying the readmission process. Some 
hospitals have returning CHF patients placed under observation criteria for fear of 
readmission penalties, while other hospitals consider returning CHF patients as 
readmissions with 30 days. This threat narrows the characteristics of participants in the 
study (Creswell, 2009).  
Internal Validity 
Threats to internal validity pertain to the subjective experiences of the 
participants. Participants were selected with certain characteristics that could predispose 
them to have certain outcomes. For example, this study used CHF as the only diagnosis.   
Access to care and conditions of severity are highly subjective between patients. Internal 
validity can be minimized by taking preventive action (Trochim, Donnelly, & Arora, 
2016, p. 217).   
Ethical Procedures 
Patient-specific information was protected and de-identified before being reported 
to the Office of Statewide Health Planning and Development, which is the primary source 
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of data for this study. Since the data is de-identified, there is no risk associated with the 
disclosure of confidential information from the dataset obtained. Anonymity and 
confidentiality of the OSHPD data are strictly maintained (Creswell, 2009). A review of 
ethical procedures and the protection of human subjects was obtained from the Walden 
University Institute Review Board. The dataset for this study was stored on my personal 
computer, password-restricted, and secured and was deleted after the research was 
completed. 
Summary 
The purpose of this study was to examine the differences between hospital 
readmission rates, and insurance reimbursement rates for Blacks, non-Hispanic and 
Whites, non-Hispanic patients with congestive heart failure.  In this section, the study 
design and rationale were addressed, indicating the population investigated, the source of 
data, the data collection procedure, and data analysis strategy and techniques. Also, 
threats to validity and ethical methods were discussed. Section two provides the 
methodology and research design for this study. Section Three provides a statistical 




Section 3: Presentation of the Results and Findings 
Introduction 
The purpose of this study was to examine the differences between hospital 
readmission rates and insurance reimbursement rates for Blacks, non-Hispanic, and 
Whites, non-Hispanic with CHF in California. The theoretical framework was Bandura’s 
(1986) SCT, which addresses health behaviors and habits. This theory has been used 
extensively in healthcare communication as it pertains to the modeling of behaviors and 
improvements in processes that could be used to facilitate and improve care for CHF 
patients (Pajares et al. 2017).  Findings from this study may help healthcare 
administrators identify a better approach for providing care to Black, non-Hispanic 
patients with CHF to reduce the readmission phenomenon.    
I used a correlational design to determine if there were any statistically significant 
differences between hospital readmission rates and insurance reimbursement rates for 
Black, non-Hispanic CHF patients, and White, non-Hispanic CHF patients.  Categories 
for reimbursement included average total reimbursements, average Medicare 
reimbursements, average Medicaid reimbursements, average private insurance 
reimbursements, and average uninsured private pay reimbursements.  The primary 
correlational tests used for the analyses were the t-test and Levene’s test for equality of 
variances.   
Research Questions and Hypotheses 
RQ 1. What is the difference, if any, between hospital CHF readmission rates for 
Blacks, non-Hispanic and Whites, non-Hispanic in California?  
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H11: There is a statistically significant difference between hospital CHF 
readmission rates for Blacks, non-Hispanic, and Whites, non-Hispanic in 
California. 
H01: There is not a statistically significant difference between hospital CHF 
readmission rates for Blacks, non-Hispanic, and Whites, non-Hispanic in 
California. 
RQ 2: What is the difference, if any, between hospital CHF readmission insurance 
reimbursement for Blacks, non-Hispanic and Whites, non-Hispanic in California? 
H12: There is a statistically significant difference between hospital CHF 
readmission insurance reimbursement for Blacks, non-Hispanic and Whites, non-
Hispanic in California. 
H02: There is not a statistically significant difference between hospital CHF 
readmission insurance reimbursement for Blacks, non-Hispanic and Whites, non-
Hispanic in California. 
Data Collection of Secondary Data Set 
Time Frame and Discrepancies of the Data Set 
The data collection involved downloading readmission discharge data from the 
OSHPD for calendar years 2014-2016 and SID for calendar years 2014-2016 from 
HCUP. Using the provider report from CMS, I was able to examine the following 
explanatory variables diagnosis-related group (DRG), provider ID, provider zip code, 
total discharged, average covered charges, average total reimbursements, average 
Medicare reimbursements, average Medicaid reimbursements, and average private 
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insurance reimbursements, average uninsured private pay reimbursements, age (mean), 
and break-out. The variables for insurance reimbursement were categorized as follows: 
average total reimbursements, average Medicare reimbursements, average Medicaid 
reimbursements, average private insurance reimbursements, and average uninsured 
private pay reimbursements.  The statewide data for calendar years 2014-2016 obtained 
from HCUP and OSPHD met the readmission and discharged criteria therefore, the data 
collected had no discrepancies. The data presented discharged CHF patients who were 
readmitted within 30 days of initial discharge. Thus, the number of CHF discharges for 
patients classified as readmitted was used to analyze the differences between readmission 
rates and reimbursement rates for Blacks, non-Hispanic, and Whites, non-Hispanic in 
California.    
Descriptive and Demographic Characteristics of Sample  
The data analysis process began after I received Institutional Review Board 
approval from Walden University; the approval number is 05-01-19-0649191. All data 
files were extracted and downloaded into Excel software. I identified 677 hospitals 
statewide in California with progressive CHF readmission discharge. The data obtained 
were comprised of the following ethnic groups: Blacks, non-Hispanic, Whites, non-
Hispanic, Asians, non-Hispanic, and Hispanics. 
Table 1 presents the descriptive statistics for ethnicity within the sample. The 
sample consisted of the following groups of CHF patients: Blacks, non-Hispanic at 240 
(36%); Whites, non-Hispanic at 195 (29%); Asians, non-Hispanic at 84 (12%), and 
Hispanics at 110 (16%).  My research questions focused on Blacks, non-Hispanic, and 
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Whites, non-Hispanic. Asians non-Hispanic and Hispanic populations were included in 
the descriptive analysis and in Table 1 to illustrate the composition of the data collection. 
The reason for including non-Hispanic Asians, Hispanics, and other ethnic groups in the 
descriptive analysis is to show the CHF readmission phenomenon in the State of 
California and to highlight the CHF readmission levels with different ethnicities besides 
Blacks, non-Hispanic and Whites, non-Hispanic. 
Table 1  
Descriptive Statistics for Ethnicity 
Ethnic group N % 
Hispanic 110 16% 
Non–Hispanic Asian 84 12% 
Non–Hispanic Black 240 36% 
Non–Hispanic White 195 29% 
Other 46 7% 
 
Results 
Statistical Assumptions for RQ 1: CHF Readmission Rates 
RQ 1. What is the difference, if any, between hospital CHF readmission rates for 
Blacks, non-Hispanic and Whites, non-Hispanic in California?  
T-Test. I conducted a t-test to test for the difference in mean readmission 
discharges for non-Hispanic Black and White CHF patients. I performed the test to 
evaluate the assumption of equal variance in each group to determine if they were similar 
to each other. I assumed that, if the Levene’s test is significant (p <. 05), then the 
variance of the groups would be significantly different from each other, and therefore, 
equal variance would not be assumed. However, if the Levene’s test was not statistically 
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significant (p > .05), then the variance would not be significantly different, and then 
equal variance would be assumed (see Table 2). 
Analysis. The t-test analysis for Figure 1 shows that for this particular analysis, 
the assumption of equal variances between the groups was not violated (Levene’s test, F 
= .454, p = .501). In this scenario, the analysis for equal variance is assumed and 
therefore can be used for these analyses. An independent t-test was conducted to compare 
the total number of CHF readmission discharges in Blacks, non-Hispanic and Whites, 
non-Hispanic, and the results show that there was not a significant difference between the 
average number of readmission discharges for Blacks, non-Hispanic (M = 49.6, SD = 
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Statistical Assumptions for RQ 2: CHF Readmission Insurance Reimbursement 
Rates 
RQ 2: What is the difference, if any, between hospital CHF readmission insurance 
reimbursement for Blacks, non-Hispanic and Whites, non-Hispanic in California? 
Statistical assumptions for all insurance elements. A t-test was conducted to 
test for the difference in the average readmission insurance reimbursement rate for non-
Hispanic Black and White CHF patients. The t-test analysis in Figure 2 shows that for 
this particular analysis, the assumption of equal variance between the groups violated 
Levene’s Test, (F=4.033, p=.045) therefore the analysis for equal variance is used for the 
analysis, however, in this situation, the equal variance is not assumed. An independent t-
test conducted to compare the average insurance reimbursement rates for Blacks, non-
Hispanic and Whites, non-Hispanic, the results showed that the result of the groups are 
not significantly different; Blacks, non-Hispanic (M = 9987.82, SD = 4098.29) and Non-
Hispanic Whites (M = 10058.05, SD = 3990.81), t = -.183, p = .855. Therefore, there is 
not a statistically significant difference between Blacks, non-Hispanic, and Whites, non-
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Figure 2. Independent samples test for average total insurance reimbursement rates. 
 
 
Table 2.  
Descriptive Statistics for Average Medicare Payments by Group Variable  
Ethnic group N Mean SD SE 
Non-Hispanic Black 240 9127.19 4139.30 267.19 
Non-Hispanic White  195 9248.69 3869.47 277.10 
 
Statistical assumptions for Medicare payments.  A t-test was conducted to test 
for the difference in average readmission Medicare payments reimbursements for non-
Hispanic Black and White CHF patients. The t-test analysis in Figure 3 shows that for 
this particular analysis, the assumption of equal variances between the groups is violated 
(Levene’s Test, F = 4.188, p = .041). Thus, the analysis for equal variances not assumed. 
An independent t-test was conducted to compare the average Medicare insurance 
reimbursement rates for non-Hispanic Black and White CHF patients. There was not a 
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significant difference between the average Medicare reimbursement rates for Non-
Hispanic Blacks (M = 9127.19, SD = 4139.30) and Non-Hispanic Whites (M = 9248.69, 
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-.316 424.549 .752 -121.49420 384.93398 -878.10789 635.11949 
 
Figure 3. Independent samples test average Medicare reimbursement rates. 
 
Table 3.  
Descriptive Statistics for Average Medicaid Payments by Group Variable  
Ethic group N Mean SD SE 
Non-Hispanic Black 240 2678.42 625.36 40.37 
Non-Hispanic White  195 2656.82 636.18 45.56 
 
Statistical assumptions for Medicaid payments. A t-test was conducted to test 
for the difference in average readmission Medicaid reimbursement rates for non-Hispanic 
Black and White CHF patients. The t-test analysis in Figure 4 shows that for this 
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particular analysis, the assumption of equal variances between the groups is not violated 
(Levene’s Test, F = .126, p = .722). Thus, the analysis of equal variances is assumed. An 
independent t-test was conducted to compare the average Medicaid reimbursement rates 
for non-Hispanic Black and White CHF patients. There was not a significant difference 
between the average Medicaid reimbursement rates for Non-Hispanic Blacks (M = 
9127.19, SD = 4139.30) and Non-Hispanic Whites (M = 9248.69, SD = 3869.47), t = 
.356, p = .722 who were readmitted with CHF. 
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  .355 412.041 .723 21.60128 60.86898 -98.05119 141.25374 
 
Figure 4. Independent samples test average for Medicaid reimbursement rates. 
 
Table 4.  
Descriptive Statistics for Average Private Insurance Payments by Group Variable  
        Ethic group N Mean SD      SE 
Non-Hispanic Black 240 1381.90 224.84    14.51 
Non-Hispanic White  195 1384.90 218.48    15.65 
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Statistical assumptions for private insurance payment.  A t-test was conducted 
to test for the differences in average private payment reimbursement rates for Blacks, 
non-Hispanic, and Whites, non-Hispanic. The t-test analysis in Figure 5 shows that for 
this particular analysis, the assumption of equal variances between the groups is not 
violated (Levene’s Test, F = .031, p = .86). Thus, the analysis of equal variances is 
assumed. An independent t-test was conducted to compare the average private insurance 
reimbursement rates for non-Hispanic Black and White CHF patients. There was not a 
significant difference between the average private insurance reimbursement rates for non-
Hispanic Blacks (M =1381.90, SD = 224.84) and non-Hispanic Whites (M = 1384.90, SD 
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Table 5.  
 
Descriptive Statistics for Uninsured Private Payments by Group Variable  
 
       Ethic group N Mean SD SE 
Non-Hispanic Black 240 635.21 331.52 21.40 
Non-Hispanic White  195 652.77 328.33 23.51 
 
Statistical assumptions for uninsured private payments. A t-test was 
conducted to test for the difference in average readmission uninsured private payment 
reimbursement for non-Hispanic Black and White CHF patients. The t-test analysis for 
Figure 6 shows that for this particular analysis, the assumption of equal variances 
between the groups is not violated (Levene’s Test, F = .701, p = .403). Thus, the analysis 
for equal variances assumed. An independent t-test was conducted to compare the 
average of uninsured private payment reimbursement rates for non-Hispanic Black and 
White CHF patients. There was not a significant difference between the average 
uninsured private payment reimbursement rates for Blacks, non-Hispanic (M =635.21, 
SD = 331.52) and Whites, non-Hispanic (M = 652.77, SD = 328.33), t = -.552, p = .58 
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Figure 6. Independent samples test average for uninsured reimbursement rates. 
 
Results for Research Question 1 
RQ 1 concerned whether there were significant differences in readmission rates 
for non-Hispanic Black and White CHF patients. Based on the analysis conducted, the 
results indicated that even though Black, non-Hispanic readmission rates were N =240 as 
compared to Whites, non-Hispanic N =195, there was not a statistically significant 
difference in the readmission rates.   
Hypothesis acceptance for RQ 1. As a result of the analyses using the t-test and 
Levene’s Test for Equality of Variances, the null hypothesis was accepted, which stated 
that there is not a statistically significant difference between hospital readmission rates 
for Blacks, non-Hispanic, and Whites, non-Hispanic readmitted with CHF in California. 
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Results for Research Question 2 
RQ 2 addressed concerns about whether there were significant differences in 
insurance reimbursement rates. All-payer types were analyzed, and they included: 
Medicare, Medicaid, private insurance reimbursement, and uninsured private payment 
reimbursement.   
Medicare. The results indicated that for average Medicare reimbursement rates 
there was not a statistically significant difference between the average Medicare 
reimbursement rates for non-Hispanic Blacks (M = 9127.19, SD = 4139.30) and non-
Hispanic Whites (M = 9248.69, SD = 3869.47), t = -.316, p = .752. 
Medicaid.  The results indicated that for average Medicaid reimbursement rates 
there was not a statistically significant difference between the average Medicaid 
reimbursement rates for non-Hispanic Blacks (M = 9127.19, SD = 4139.30) and non-
Hispanic Whites (M = 9248.69, SD = 3869.47), t = .356, p = .722. 
Private insurance reimbursement. The results indicated that for average private 
insurance reimbursement rates there was not a statistically significant difference between 
the average private payment reimbursement rates for non-Hispanic Blacks (M =1381.90, 
SD = 224.84) and non-Hispanic Whites (M = 1384.90, SD = 218.48), t = -.14, p = .89. 
Uninsured private payment reimbursement.  The results indicated that for 
average uninsured reimbursement rates there was not a statistically significant difference 
between the average uninsured private payment reimbursement rates for Non-Hispanic 
Blacks (M =635.21, SD = 331.52) and Non-Hispanic Whites (M = 652.77, SD = 328.33), 
t = -.552, p = .58.  
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Hypothesis acceptance for RQ 2. As a result of the analyses for these payment 
types consisting of a t-test and Levene’s Test for Equality of Variances the results 
indicated that the null hypothesis was accepted which stated that there is not a statistically 
significant difference between hospital reimbursement rates for Blacks, non-Hispanic, 
and Whites, non-Hispanic readmitted with CHF in California. 
Summary 
The purpose of this study was to examine the correlation between hospital 
readmission rates, and reimbursement rates for Blacks, non- Hispanic and Whites, non-
Hispanic with congestive heart failure in California. In Section 3 secondary data from the 
Office of Statewide Health Planning and Development (OSHPD) for calendar years 
2014- 2016 and State Inpatient Databases (SID) for calendar years 2014- 2016 from 
Healthcare Cost and Utilization Project (HCUP) were analyzed using the t-test and 
Levene’s Test for Equality of Variances. Based on the hospital CHF readmission 
discharge rates, the results of the analyses indicated that there were no significant 
differences between non-Hispanic Black and White CHF patients concerning readmission 
rates and reimbursement rates. 
In Section 4, the interpretation of findings and limitations of the study will be 
further examined.  Bandura’s Social Cognitive Theory is the framework for this research, 
and the results of this study will be addressed concerning positive health behaviors. This 
section will also discuss the recommendations for future research and the implication of 




Section 4: Application to Professional Practice and Implications for Social Change 
Introduction 
The purpose of this study was to examine the differences between hospital 
readmission rates and insurance reimbursement rates for non-Hispanic Black and White 
patients with CHF who live in California. I obtained the secondary data for this study 
from the OSHPD for calendar years 2014-2016 and SID for calendar years 2014-2016 
from HCUP.  Statistical analyses were performed using a t-test, along with Levene’s test 
for equality of variances. The findings of the t-test indicated no significant differences 
between readmission rates and insurance reimbursement rates for Blacks, non-Hispanic, 
and Whites, non-Hispanic. 
In addition to the t-tests, I conducted a descriptive analysis of the population for 
each variable.  I used SPSS software for data analyses and did not report values less than 
10, as per HCUP SID reporting guidelines (HCUP SID, 2018).  Bandura’s (1987) SCT, 
which was the framework of this study, has as a tenet that personal efficacy has an impact 
on how one can reinforce or carry out personal changes. I surmised that this central belief 
of change would be the fundamental factor to motivate Blacks, non-Hispanic, to take 
action to improve health behaviors.  Section 4 includes an interpretation of the findings, 
discussion of limitations of the study, recommendations for further research, and 
consideration of the study’s implications for professional practice and social change. 
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Interpretation of the Findings 
RQ 1: CHF Readmission Rates 
I conducted an independent t-test to compare the total number of CHF 
readmission discharges for Blacks, non-Hispanic and Whites, non-Hispanic. The results 
indicated that there is not a statistically significant difference between the average 
number of readmission discharges for Blacks, non-Hispanic (M = 49.6, SD = 38.28) and 
Whites, non-Hispanic (M =50.88, SD = 36.52), t = -.352, p = .725. The test results exceed 
the p-value of 5%; therefore, the null hypothesis, which stated that there is not a 
statistically significant difference between hospital CHF readmission rates for Blacks, 
non-Hispanic, and Whites, non-Hispanic in California, is accepted.  
Even though readmission rates for Blacks (36%) were higher than those for 
Whites (29%) based on the data obtained from OSHPD and HCUP, there was not a 
statistically significant difference. Since the p-value is .725, healthcare administrators 
would not reasonably use this study as a basis for determining if hospital readmission 
rates for Blacks, non-Hispanic are different than those of Whites, non-Hispanic.  
However, the research related to this study has shown the importance of developing 
programs that link hospitals, CHF patients, and providers to partners and establishing 
protocols and communication to improve outcomes and reduce readmissions 
(Chamberlain, Sond, Mahendraraj, Lau, & Siracuse, 2018). Developing these programs is 
appropriate and necessary because CHF patients experience care in numerous settings, 
including primary care, inpatient, and post-acute. The goal is to minimize readmissions, 
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as emphasized in the one million hearts campaign designed by CMS and Centers for 
Disease Control and Prevention (Sanghavi et al., 2015).   
RQ 2: Insurance Reimbursement Rates (All-Payer Types) for CHF Readmissions 
I conducted an independent t-test analysis to compare the differences between the 
average reimbursement rates, and the results indicated for Medicare reimbursement rates 
between Blacks, non-Hispanic and Whites, non-Hispanic there was not a statistically 
significant difference. The average reimbursement rates for Medicare were analyzed, and 
the results indicated that there was not a statistically significant difference between the 
average Medicare reimbursement rates for non-Hispanic Blacks (M = 9127.19, SD = 
4139.30) and non-Hispanic Whites (M = 9248.69, SD = 3869.47), t = -.316, p = .752. The 
test results exceed the p-value of 5%, indicating there is no likelihood that there are 
differences in average Medicare readmission reimbursement rates. 
Second, an independent t-test analysis was conducted to examine the average 
Medicaid reimbursement rates, the results indicated that there was not a significant 
difference between the average Medicaid reimbursement rates for non-Hispanic Blacks 
(M = 9127.19, SD = 4139.30) and non-Hispanic Whites (M = 9248.69, SD = 3869.47), t = 
.356, p = .722. The test results exceed the p-value of 5%, further indicating there is no 
likelihood that there are differences in average Medicaid readmission reimbursement 
rates. 
Thirdly, an independent t-test analysis was conducted to examine the average 
private insurance reimbursement rates. The results indicated that there was not a 
significant difference between the average private payment reimbursement rates for non-
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Hispanic Blacks (M =1381.90, SD = 224.84) and non-Hispanic Whites (M = 1384.90, SD 
= 218.48), t = -.14, p = .89. The test results exceed the p-value of 5%, indicating there is 
no likelihood that there are differences in average private insurance readmission 
reimbursement rates. 
Lastly, an independent t-test analysis was conducted to examine the average 
uninsured private pay reimbursement rates. The results indicated that there was not a 
significant difference between the average uninsured private pay reimbursement rates for 
Blacks, non-Hispanic (M =635.21, SD = 331.52) and Whites, non-Hispanic (M = 652.77, 
SD = 328.33), t = -.552, p = .58.  The test results exceed the p-value of 5%, indicating 
there is no likelihood that there are differences in average uninsured private pay 
readmission reimbursement rates. Therefore, the null hypothesis was accepted, which 
stated that there is not a statistically significant difference between hospital CHF 
reimbursement for Blacks, non-Hispanic, and Whites, non-Hispanic in California.  
General Discussion 
CHF accounts for one million hospitalizations annually (Basu et al., 2018). 
According to Piamjariyakul et al. (2015), the excessive financial burden associated with 
CHF readmissions and many other chronic conditions is driven by the disintegrated and 
uncoordinated health system. Reducing readmissions not only reduces health care 
expenditures but also importantly improves patient outcomes (Chamberlain et al., 2018). 
This study contributes to current research by highlighting the readmission and 
reimbursement patterns of non-Hispanic Black and White CHF patients in California. 
The Hospital Readmission Reduction Program (HRRP) was established as part of the 
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PPACA to provide a financial incentive to hospitals to engage in quality improvement 
efforts to reduce readmission (Kulaylat, Jung, Hollenbeak, & Messaris, 2018). This 
program levied penalties on hospitals with higher-than-normal readmission rates. The 
goal of this program was to link payment with the quality of care to minimize the 
disparity between hospitals and reduce readmission (Bergethon et al., 2017).   
Findings in Relation to Theoretical Framework 
Drawing from the theoretical framework of this study, SCT (Bandura, 1997), 
beliefs of personal efficacy have an impact on how one can enforce or carry out personal 
changes. This central belief of change is the fundamental factor to motivate Blacks, non-
Hispanic, to take action to improve health behaviors (D’Angelo & Lawson, 2018). The 
SCT indicates that behaviors are regulated by social approval and disapproval, and 
consequently, this behavior allows people to adapt to personal principles and adjust their 
behavioral patterns by self-evaluation, which will enable them to do activities purposely 
to gain self-satisfaction (Jeihooni et al., 2016). 
SCT relates to this study because beliefs influence purposes and aspirations (see 
Cherry, 2019). If one’s perceived self-efficacy is stronger, then there are tendencies that 
one would set higher goals and commit to those goals (Jeihooni et al., 2016). The 
personal change would be easy if there were no impediments to surmount. Self-efficacy 
belief must be measured against the challenges to accomplish change. For example, for a 
CHF patient to acknowledge lifestyle changes and compliance with an exercise routine, 
the CHF patient needs to judge self-efficacy in order to accomplish these exercise goals 
under stressful circumstances and obstacles. If there are no impediments to surmount, 
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then the goals will be attained.  Self-efficacy beliefs shape outcomes (Cherry, 2019). 
Accepting and redefining healthy choices paves the way for better results. According to 
Sanghavi et al. (2016), it is estimated that behavior accounts for 80% cardiovascular 
disease. Non-Hispanic Blacks face unique challenges to adhere to dietary and exercise 
recommendations as compared to their White counterparts; as a result, there is a high 
propensity of readmission rates for Blacks, non-Hispanic (Carnethon et al., 2017).  
Limitations of the Study 
The study methodology has provided the strength for this study; a t-test analysis 
was conducted to test for the differences between hospital readmission and insurance 
reimbursement for Black, non-Hispanic and White, non-Hispanic patients with CHF in 
California. In this study, several limitations were identified: firstly, the differences in 
insurance reimbursement rates between these ethnic groups and hospital readmissions. 
The rising health cost and increasing disparity in the quality of healthcare have spurred 
payment reform initiatives. Secondly, reliance on billing codes for identification of CHF 
and cardiovascular diseases may result in misclassification. Thirdly, the HCUP data 
2014-2016 indicated that not all statewide inpatient data files contain American Heart 
Association linkage data elements; therefore, the data linkage in this study might have 
some few discrepancies providing a variance between the Blacks, non-Hispanic and 
Whites, non-Hispanic. Thirdly, in this study context, the population is not reflective of 
racial/ethnic distribution of the United States population. Finally, the recording of 
demographic information, including race and ethnicity, during the admission registration 




 Non-Hispanic Blacks in this study have a readmission rate of 36%, and Whites, 
non-Hispanic have a readmission rate of 29%. The t-test analytic results indicated that the 
differences are not statistically significant even though Blacks, non-Hispanic have the 
highest risk of heart failure as compared to their White counterparts. The prominence of 
disparities in the onset of CHF at a younger age highlights cardiovascular risk and an 
increased rate of readmissions (Carnethon et al., 2017). Differences in heart failure 
management are a significant drawback (Fonarrow, Konstam, & Yancy, 2017). Further 
research is needed to expand on the trend of readmission rates for non-Hispanic Black 
and White CHF patients compared to other racial/ethnic groups in California. Secondly, 
further research is needed to expand on the appropriateness of insurance reimbursement 
rates for average Medicare reimbursement, average Medicaid reimbursement, average 
private insurance reimbursement, and average uninsured private pay reimbursement rates 
for CHF readmissions to determine discrepancies related to racial/ethnic groups.  
Implications for Professional Practice and Positive Social Change 
As part of the Patient Protection and Affordable Care Act, significant reforms 
have been enacted to improve health care outcomes and quality of care to prevent 
hospital rehospitalization and decreased health care costs (Boesen, Leal, Sheehan, & 
Sobolik, 2015, p. 237). Boesen et al., (2015) indicated that the CMS reported that 
improving health insurance status, access to care, and quality of care for racial minority 
groups reduces rehospitalization. Studies have shown that such quality of care entails 
ensuring that (i) the patient is clinically ready for discharge (ii) communication with 
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health care providers improves and enhances patient education and (iii) resources that 
affect the optimal management of CHF are provided. The subsequent paragraphs expand 
on the implications for professional practice and positive social change. 
Professional Practice 
According to Piamjariyakul et al. (2015), financial assessments and referrals to 
social services are crucial for assistance with patients’ expenses and cost of care to 
prevent rehospitalization and improve health outcomes. Strategies to prevent CHF and 
improve efficiency can be optimized if patients have more opportunities to participate in 
the management of their care.  According to Kulaylat et al. (2018), racial differences 
exist and affect care utilization; however, health care administrators can develop new 
ways to approach health care to eliminate racial/ethnic disparities and promote patient-
centered care.  Boustani et al. (2019), discussed the need to develop Agile 
Implementations (AI) as a way to use evidence-based services in their organizations. By 
identifying opportunities and developing processes that focus on system improvements, 
care for all patients can be improved.  Over the next generation, CHF will continue to 
increase if current approaches to care are not improved (Bergethon et al., 2017).  
Healthy People 2030 Framework, published in June of 2018, presented similar views 
toward changing the current method of providing health care to the American people. The 
focus of the Healthy People 2030 Framework is improving health care for the American 
people, through a healthy heart-healthy family approach. This cardiovascular information 
provides education aimed at promoting improvements in heart care by sharing evidence-
based data from a diverse group of health professionals (Healthy People 2030, 2018).      
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Positive Social Change 
Congestive heart failure is a substantial health burden in the United States, 
affecting 5.7 million at an annual cost of 30.7 billion (Boesen et al., 2015). This study 
indicated that non-Hispanic Blacks had the highest readmission rate of 36% as opposed 
to 29% for non-Hispanic Whites. Identifying an organization’s internal strengths and 
weaknesses is a challenging yet essential aspect of health care organizations to combat 
hospital readmission and improve insurance reimbursement rates for racial/ethnic groups.  
A critical component of strategic momentum is pointed out by Chamberlain et al. 
(2018) through evaluation of the organization’s strengths and weaknesses relative to the 
environment, such as ethnic/racial diversity, aging population, regulatory changes, and 
the growing use of technology. The study supports the purpose of this research 
concerning the need to decrease ethnic disparities for non-Hispanic Black CHF patients 
in order to reduce readmissions.  This research will add to positive social change through 
the recognition and emphasis on the need to educate and care for all CHF patients 
according to their health needs and based on their unique characteristics (Chamberlain et 
al., 2018). 
Conclusion 
Readmission is a significant concern for hospital administrators and health care 
providers. I conducted a t-test to examine the differences between hospital readmission 
and insurance reimbursement rates for non-Hispanic Black and White patients with CHF 
in California. The results of the t-test analysis indicated that first, there was not a 
statistically significant difference in hospital readmission rates between these two ethnic 
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groups. I also conducted a t-test to examine the differences between insurance 
reimbursements rates. The results of the analysis indicated that there was not a 
statistically significant difference between insurance reimbursement rates for these ethnic 
groups. Knowing that there is a disproportion in financial allocation, further research is 
required to better understand the mechanisms behind higher readmission rates for Blacks, 
non-Hispanic. 
This study addressed the gap in the literature regarding the differences between 
hospital readmission and insurance reimbursement rates for non-Hispanic Black and 
White patients with CHF in California. Knowing that there is no significant difference 
between these ethnic groups, health care providers can focus on methods to reduce CHF 
readmissions with programs that link hospitals, CHF patients, and providers to partner 
and establish protocols and communication to improve outcomes. The results of this 
study contribute to positive social change by providing information that healthcare 
professionals may be able to use to decrease CHF readmissions and improve access to 
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